JY
RKDA icon

Jeff Yass’s Arcadia Biosciences RKDA Stock Holding History

Jeff Yass’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,614
Closed -$17.4K – 14344
2026
Q1 		$17.4K Buy
+12,614
New +$24.7K ﹤0.01% 12878
2023
Q1 		– Sell
-7,060
Closed -$76.5K – 13344
2022
Q4 		$76.5K Buy
7,060
+3,241
+85% +$46.2K ﹤0.01% 11165
2022
Q3 		$81K Buy
3,819
+735
+24% +$25.1K ﹤0.01% 11873
2022
Q2 		$123K Sell
3,084
-2,656
-46% -$122K ﹤0.01% 11257
2022
Q1 		$321K Buy
5,740
+1,848
+47% +$88.1K ﹤0.01% 10108
2021
Q4 		$162K Sell
3,892
-1,451
-27% -$94.6K ﹤0.01% 11708
2021
Q3 		$442K Buy
+5,343
New +$501K ﹤0.01% 9702
2021
Q2 		– Sell
-3,391
Closed -$370K – 13149
2021
Q1 		$373K Sell
3,391
-1,173
-26% -$144K ﹤0.01% 10139
2020
Q4 		$461K Buy
4,564
+4,128
+947% +$504K ﹤0.01% 8469
2020
Q3 		$49K Buy
+436
New +$58.9K ﹤0.01% 10202
2018
Q4 		– Sell
-343
Closed -$67K – 9817
2018
Q3 		$67K Buy
+343
New +$86.2K ﹤0.01% 8753

Other funds holding RKDA

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BWM
Bullock Wealth Management Bloomington, Indiana $231M AUM

Jeff Yass's RKDA Position: Q2 2026 in Review

Jeff Yass sold out of Arcadia Biosciences (RKDA) in Q2 2026, closing a stake of 12,614 shares — an estimated $17.4K sold.

Jeff Yass first reported a position in RKDA in Q3 2018 and held it in 11 quarters. The position peaked at $461K in Q4 2020. 18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

  • Jeff Yass reported no remaining Arcadia Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 12,614 Arcadia Biosciences shares in Q2 2026, an estimated $17.4K.
  • Jeff Yass first reported a position in Arcadia Biosciences in Q3 2018 and held it in 11 quarters.
  • Jeff Yass's Arcadia Biosciences position peaked at $461K in Q4 2020.
  • 18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.